Attached files
| file | filename |
|---|---|
| EX-32.2 - CERTIFICATION - Aditxt, Inc. | f10q0920ex32-2_aditxtherap.htm |
| EX-31.2 - CERTIFICATION - Aditxt, Inc. | f10q0920ex31-2_aditxtherap.htm |
| EX-31.1 - CERTIFICATION - Aditxt, Inc. | f10q0920ex31-1_aditxtherap.htm |
| 10-Q - QUARTERLY REPORT - Aditxt, Inc. | f10q0920_aditxtherapeutics.htm |
EXHIBIT 32.1
CERTIFICATIONS
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
(Subsections (A) and (B) of Section 1350, Chapter 63 of Title 18, United States Code)
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), I, Amro Albanna, Chief Executive Officer of Aditx Therapeutics, Inc., a Delaware corporation (the “Company”), hereby certify, to my knowledge, that:
The Quarterly Report on Form 10-Q for the quarter ended September 30, 2020 (the “Form 10-Q”) of the Company fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, and information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Date: November 13, 2020 | By: | /s/ Amro Albanna |
| Name: | Amro Albanna | |
| Title: | Chief
Executive Officer (Principal Executive Officer) |